# InvaGen Pharmaceuticals, Inc. - Inspection Records Source: https://www.globalkeysolutions.net/companies/invagen-pharmaceuticals-inc/8841516b-25bb-463f-9666-11b69458c306 > Inspection records and compliance data for InvaGen Pharmaceuticals, Inc. in Hauppauge, New York. Access full analysis and detailed observations. --- ## Details - Name: InvaGen Pharmaceuticals, Inc. - FEI Number: 3003950641 - City: Hauppauge - State: New York - Country Name: United States - Address Line 1: 7 Oser Ave - Zip Code: 11788 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK ## Related Documents - [483 - InvaGen Pharmaceuticals, Inc. - Unknown Date](https://www.globalkeysolutions.net/records/483/invagen-pharmaceuticals-inc/4386aad6-6947-4ea2-92d6-9da36356a820) — source: FDA, date: Invalid Date - [483 - InvaGen Pharmaceuticals, Inc. - 2026-02-09](https://www.globalkeysolutions.net/records/483/invagen-pharmaceuticals-inc/53ec2c0f-6929-4a63-ae0b-a864da68445c) — source: FDA, date: February 9, 2026 - [FDA Inspection 1302076 - InvaGen Pharmaceuticals, Inc. - 2026-02-09](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/6f49afaf-f928-4ba0-a5bc-1df3f32d761d) — source: FDA, date: February 9, 2026 - [FDA Inspection 1223321 - InvaGen Pharmaceuticals, Inc. - 2023-10-25](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/ab7f3625-f61f-420c-9396-b2e66e188b6d) — classification: No Action Indicated (NAI), source: FDA, date: October 25, 2023 - [483 - InvaGen Pharmaceuticals, Inc. - 2019-12-06](https://www.globalkeysolutions.net/records/483/invagen-pharmaceuticals-inc/0d160542-dc31-422d-ae64-99643402a0c5) — source: FDA, date: December 6, 2019 - [EIR - InvaGen Pharmaceuticals, Inc. - 2019-12-06](https://www.globalkeysolutions.net/records/eir/invagen-pharmaceuticals-inc/dc2ab2c9-e4f4-4c34-ba49-691cf2a6eac6) — source: FDA, date: December 6, 2019 - [FDA Inspection 1111971 - InvaGen Pharmaceuticals, Inc. - 2019-12-06](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/c8e75b2a-217b-40b5-9c72-f760213ca045) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2019 - [483 - InvaGen Pharmaceuticals, Inc. - 2018-05-25](https://www.globalkeysolutions.net/records/483/invagen-pharmaceuticals-inc/a6dbd9aa-b64c-4e7b-a80b-5e4415cf4427) — source: FDA, date: May 25, 2018 - [FDA Inspection 1053263 - InvaGen Pharmaceuticals, Inc. - 2018-05-25](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/e3d4a9c8-e980-4a32-9fdf-d26c6a11a868) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2018 - [FDA Inspection 1007073 - InvaGen Pharmaceuticals, Inc. - 2017-03-30](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/dcaac525-f15c-4af7-b544-7f96f6648e7f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 30, 2017 - [FDA Inspection 970802 - InvaGen Pharmaceuticals, Inc. - 2016-04-20](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/8476f5de-f564-4bca-a923-100d7dbb3e57) — classification: No Action Indicated (NAI), source: FDA, date: April 20, 2016 - [483 - InvaGen Pharmaceuticals, Inc. - 2015-05-26](https://www.globalkeysolutions.net/records/483/invagen-pharmaceuticals-inc/9b59fb71-e2c5-4425-8b81-435bdfc881b7) — source: FDA, date: May 26, 2015 - [FDA Inspection 926606 - InvaGen Pharmaceuticals, Inc. - 2015-05-26](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/9ab71913-0ae6-48e5-ae65-a350690316a8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2015 - [EIR - InvaGen Pharmaceuticals, Inc. - 2015-03-13](https://www.globalkeysolutions.net/records/eir/invagen-pharmaceuticals-inc/701032da-342e-43e5-be08-0f4783273bd6) — source: FDA, date: March 13, 2015 - [FDA Inspection 917130 - InvaGen Pharmaceuticals, Inc. - 2015-03-13](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/9b5e7b14-de5e-4986-be12-dbacf5b57a6f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2015 - [FDA Inspection 917130 - InvaGen Pharmaceuticals, Inc. - 2015-03-13](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/cefce869-c006-4524-b191-87b1ed34f050) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2015 - [FDA Inspection 821197 - InvaGen Pharmaceuticals, Inc. - 2013-03-08](https://www.globalkeysolutions.net/records/fda_inspections/invagen-pharmaceuticals-inc/d2aa8f08-656b-4cc2-a0e9-a4f5a0e0f832) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2013 ## Related Companies - [Blaine Labs Inc](https://www.globalkeysolutions.net/companies/blaine-labs-inc/9b08b501-8f11-452d-914e-3f5339cbed81) - [Milbar Laboratories, Inc.](https://www.globalkeysolutions.net/companies/milbar-laboratories-inc/f2d60bc9-405c-493a-a422-7a93d38d883b) - [Pharbil Waltrop Gmbh](https://www.globalkeysolutions.net/companies/pharbil-waltrop-gmbh/f3455dea-04cf-4c53-ab8b-3fcddc45fb4c) - [Optikem International, Inc.](https://www.globalkeysolutions.net/companies/optikem-international-inc/6d89f8c9-2ba5-4826-a8e3-e71a5a10fb3e) - [Alembic Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/alembic-pharmaceuticals-limited/922eba08-7d55-42d2-9d7e-d116c041af25) - [Wasatch Product Development, LLC](https://www.globalkeysolutions.net/companies/wasatch-product-development-llc/3545661f-a68f-404a-895d-c00555648648) - [Episciences Inc](https://www.globalkeysolutions.net/companies/episciences-inc/db9de422-87ad-44ad-bf37-a1cd35fdb978) - [Clinical Formula LLC](https://www.globalkeysolutions.net/companies/clinical-formula-llc/8a18d62e-efa3-4bb2-847e-b4fe3a8bdea5) - [Kath Khemicals LLC](https://www.globalkeysolutions.net/companies/kath-khemicals-llc/9c1c329b-5bad-4e24-b029-b8ea36f97f40) - [Massco Dental](https://www.globalkeysolutions.net/companies/massco-dental/ee29f974-dddf-4781-a394-c4622b74a26b) ## Related Officers - [recipient](https://www.globalkeysolutions.net/people/madhava-u-reddy/1410cdbd-693b-42d9-bd0a-b9d199dcabea) - [company_representative](https://www.globalkeysolutions.net/people/ram-mobam-kathuroju/21f4718f-a47b-46f7-9ecc-b6181ef42efd) - [Biotechnology Specialist at FDA](https://www.globalkeysolutions.net/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd) - [Dipesh K. Shah](https://www.globalkeysolutions.net/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)